Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients
Authors:
- 1 February 2020
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 77 (2) , 257-259
Abstract
Myelin oligodendrocyte glycoprotein (MOG)–IgG is a biomarker associated with central nervous system–demyelinating disorders termed MOG-IgG–associated disorders. These disorders have overlapping clinical features, including optic neuritis and myelitis, with aquaporin-4 (AQP4)–IgG–positive neuromyelitis optica spectrum disorders. These disorders are hypothesized to be biologically distinct; AQP4-IgG–positive neuromyelitis optica spectrum disorders are autoimmune astrocytopathies, whereas MOG-IgG–associated disorders are postulated to be autoimmune oligodendrocytopathies.1 Despite their immunopathogenic differences, there are rare reports of patients with dual positivity of MOG-IgG and AQP4-IgG.2,3 We aimed to determine the frequency, sex ratio, and coexistence of glial antibodies (AQP4-IgG and MOG-IgG) in adults and children undergoing evaluation for suspected central nervous system–demyelinating diseases.Keywords
This publication has 5 references indexed in Scilit:
- A multicenter comparison of MOG-IgG cell-based assaysNeurology, 2019
- Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseasesJournal of Neurology, Neurosurgery & Psychiatry, 2017
- Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin‐4 channelopathies: a decade laterAnnals of the New York Academy of Sciences, 2015
- Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseMultiple Sclerosis Journal, 2014
- Effects of Age and Sex on Aquaporin-4 AutoimmunityArchives of Neurology, 2012